CIPLA FDA Approval ANDA 214209

ANDA 214209

CIPLA

FDA Drug Application

Application #214209

Application Sponsors

ANDA 214209CIPLA

Marketing Status

Prescription001

Application Products

001SPRAY;NASAL20MG/SPRAY0SUMATRIPTANSUMATRIPTAN

FDA Submissions

UNKNOWN; ORIG1AP2021-02-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214209
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"SUMATRIPTAN","activeIngredients":"SUMATRIPTAN","strength":"20MG\/SPRAY","dosageForm":"SPRAY;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/22\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-02-22
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.